Find Articles



Return to:Anxiety Articles
Or:Recent Anxiety Articles

MediciNova Reports Phase IIa Clinical Study Results for MN-305, a ...


http://news.moneycentral.msn.com/provider/providerarticle...

MSN MoneyCentral - MN-305 is a potent and highly-selective full agonist at the serotonin 5-HT1A receptor under development by MediciNova both for the treatment of insomnia, as well as for anxiety disorders such as Generalized Anxiety Disorder (GAD). MN-305 has been ...



Article Finder:

October 18, 2007 03:27:00 PM
Article Directory